User: Genecampaign Topic: IP
Category: patents :: everywhere
Last updated: Sep 21 2014 18:04 IST RSS 2.0
 
1 to 20 of 9,525    
Innovators: a lightbulb moment for Dyson and son 21.9.2014 The Guardian -- Front Page
Innovation runs in the Dyson family, with Jake refining a last-a-lifetime LED light that can illuminate a whole kitchen

From spending his summer as a teenager constructing vacuum cleaners to witnessing the frustrations of his father working in their basement, Jake Dyson has been surrounded by the highs and lows of invention for most of his life.

But while he is following in the footsteps of his father, Sir James, the 41-year-old is keen to point out his work on a new way of lighting offices and kitchens is all his own.

Continue reading...
Also found in: [+]
Obama-Modi pact on power sector in logjam 20.9.2014 Rediff: Business
US wants to include climate change deal in it; India disinclined
Also found in: [+]
Markets firm up led by IT shares; Sensex tops 27,200 19.9.2014 Rediff: Business
Markets extend gains led by IT majors and select pharma shares.
Also found in: [+]
Ig Nobels: British researchers take coveted science humour prize 19.9.2014 Guardian: Science
UK researchers reveal people who habitually stay up late are, on average, more self-admiring, manipulative and psychopathic Continue reading...
Also found in: [+]
Cipla Ltd grants Salix Pharmaceuticals Ltd rights for Rifaximin 18.9.2014 ET: Pharma
Under the agreement, Salix will make an upfront payment and milestone payments to Cipla, the companies said in separate statements.
Also found in: [+]
IITians build unique, affordable solar-powered cold storage 18.9.2014 Rediff: Top Stories (India)
Young IIT engineers have come up with an affordable solution to the wastage of agricultural produce by developing a unique solar-powered cold storage system which works at almost zero running cost.
Also found in: [+]
Cipla teams up with Gilead Lifesciences to make Hepatitis drug for MNC 17.9.2014 ET: Pharma
On the face of it, there is nothing wrong with this kind of a deal. Pharma companies ink many such pacts on a regular basis.
Also found in: [+]
Doctor pleads guilty to cancer treatment fraud 17.9.2014 Sify News
A Detroit-area cancer doctor accused of putting people through unnecessary treatments and then billing insurers for millions of dollars pleaded guilty to fraud Tuesday, admitting that he knew his
Also found in: [+]
Hepatitis C drug in India to cost 49 lakh less than in US 16.9.2014 ET: Pharma
The voluntary licencing deal promises to make the drug cheap in India as well as up to 91 countries where the Indian firms are allowed to sell it.
Also found in: [+]
Pill for thought: Sweetheart deals that hurt consumers 16.9.2014 Rediff: Top Stories (India)
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
Also found in: [+]
Epirus, Ranbaxy win India approval for arthritis drug copy 16.9.2014 ET: Pharma
Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year.
Also found in: [+]
Hepatitis C drug in India to cost 49 lakh less than in US 16.9.2014 TOI: India
Sofosbuvir, the wonder medicine for Hepatitis C that costs $84,000 or Rs 50.4 lakh for a 24-week treatment regimen in the US, will soon be available in India for about $1,800 or roughly Rs 1.1 lakh for the same ...
Also found in: [+]
Hope for 'cheap' hepatitis drug 16.9.2014 Telegraph: Nation
New Delhi, Sept. 15: A US biopharmaceutical company today announced its move to make available a medicine to treat hepatitis C virus infections in India and 90 other developing countries at prices much lower than the treatment-course cost of $84,000 (Rs 51.3 lakh) in the US.
Also found in: [+]
Health care companies' scrips canter along 16.9.2014 Sify Finance
Stocks of Indian pharmaceutical companies seem to be in the pink of health, as investor interest in these has been rising on the back of a weakening currency, the expiry of generic-drug patents later
Also found in: [+]
Government to hear out US pharma companies' patent fears 15.9.2014 ET: Pharma
The meeting itself is the fallout of discussions by a committee of secretaries, where it was felt that the government should engage with the companies.
Also found in: [+]
Ranbaxy relief 14.9.2014 Telegraph: Business
Sept. 13 (Reuters): Pfizer Inc and Ranbaxy Laboratories on Friday won dismissal of a US anti-trust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.
Also found in: [+]
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor 13.9.2014 Sify Finance
Also found in: [+]
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor 13.9.2014 Rediff: Business
Pfizer Inc and Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.
Also found in: [+]
Pfizer, Ranbaxy win dismissal of antitrust lawsuit over generic Lipitor 13.9.2014 ET: Pharma
Pfizer, Ranbaxy won dismissal of an antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor.
Also found in: [+]
Calcutta HC raps Bengal police over inaction in Tapas hate speech case 13.9.2014 TOI: India
Calcutta high court concluded the hearing of the Tapas Pal hate speech case on Friday. Justice Nishita Mhatre reserved judgment and extended the stay on an earlier single bench order for a CID ...
Also found in: [+]
1 to 20 of 9,525